Company Filing History:
2 out of 45 
1 out of 3,540 
1 out of 1 Years Active: 2007-2009
Title: M Elizabeth Snell: Innovator in Antiviral Research
Introduction
M Elizabeth Snell is a notable inventor based in Ardmore, Alabama, recognized for his contributions to antiviral research. He holds two patents that focus on innovative approaches to enhance antiviral activity through polymer conjugates.
Latest Patents
His latest patents include the development of cyanovirin variant-polymer conjugates. The present invention provides variants of cyanovirin-N and water-soluble polymer conjugates thereof. These cyanovirin-N variants are particularly suited for site-selective covalent attachment of one or more water-soluble polymers, resulting in polymer conjugates that exhibit antiviral activity.
Career Highlights
Throughout his career, M Elizabeth Snell has worked with prominent organizations such as Nektar Therapeutics and the National Institutes of Health, a component of the US Department of Health & Human Services. His work has significantly contributed to the field of antiviral research and development.
Collaborations
He has collaborated with esteemed colleagues, including Michael James Roberts and Toshiyuki Mori, further enhancing the impact of his research.
Conclusion
M Elizabeth Snell's innovative work in developing antiviral polymer conjugates showcases his dedication to advancing medical science. His contributions continue to influence the field and pave the way for future research.